BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12120506)

  • 1. Chemical database techniques in drug discovery.
    Miller MA
    Nat Rev Drug Discov; 2002 Mar; 1(3):220-7. PubMed ID: 12120506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs.
    Lewell XQ; Jones AC; Bruce CL; Harper G; Jones MM; McLay IM; Bradshaw J
    J Med Chem; 2003 Jul; 46(15):3257-74. PubMed ID: 12852756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico screening of drug databases for TSE inhibitors.
    Lorenzen S; Dunkel M; Preissner R
    Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHASE: a novel approach to pharmacophore modeling and 3D database searching.
    Dixon SL; Smondyrev AM; Rao SN
    Chem Biol Drug Des; 2006 May; 67(5):370-2. PubMed ID: 16784462
    [No Abstract]   [Full Text] [Related]  

  • 5. HAD: an automated database tool for analyzing screening hits in drug discovery.
    Shen J
    J Chem Inf Comput Sci; 2003; 43(5):1668-72. PubMed ID: 14502501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
    Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
    J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
    Macdougall IJ; Griffith R
    J Mol Graph Model; 2008 Apr; 26(7):1113-24. PubMed ID: 18023378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR in drug discovery.
    Pellecchia M; Sem DS; Wüthrich K
    Nat Rev Drug Discov; 2002 Mar; 1(3):211-9. PubMed ID: 12120505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaffold distributions in bioactive molecules, clinical trials compounds, and drugs.
    Hu Y; Bajorath J
    ChemMedChem; 2010 Feb; 5(2):187-90. PubMed ID: 20014088
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 16. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DrugBank: a comprehensive resource for in silico drug discovery and exploration.
    Wishart DS; Knox C; Guo AC; Shrivastava S; Hassanali M; Stothard P; Chang Z; Woolsey J
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D668-72. PubMed ID: 16381955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophores in drug design and discovery.
    Milne GW; Nicklaus MC; Wang S
    SAR QSAR Environ Res; 1998; 9(1-2):23-38. PubMed ID: 9517013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The properties of known drugs. 1. Molecular frameworks.
    Bemis GW; Murcko MA
    J Med Chem; 1996 Jul; 39(15):2887-93. PubMed ID: 8709122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.